CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC covid-19 IgM/IgG combo test, a quick antibody test kit on covid-19. In addition, the company offers coating base/plasticizer/pore former, diluting agents, bonding agents, disintegrating agents, lubricants, solubilizer/biopharma, topicals, APIs, and food/health functional foods, as well as animal drugs, physiological activators, functional enhancers, and disinfectants. CTCBIO Inc. was founded in 1993 and is headquartered in Hwaseong-si, South Korea.
Metrics to compare | 060590 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship060590PeersSector | |
---|---|---|---|---|
P/E Ratio | −36.0x | 4.1x | −0.5x | |
PEG Ratio | −0.52 | −0.10 | 0.00 | |
Price/Book | 2.2x | 0.9x | 2.6x | |
Price / LTM Sales | 1.1x | 0.7x | 3.2x | |
Upside (Analyst Target) | - | 25.8% | 41.4% | |
Fair Value Upside | Unlock | 22.5% | 6.0% | Unlock |